6586 Stock Overview
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
CHO Pharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$57.50 |
| 52 Week High | NT$115.50 |
| 52 Week Low | NT$51.70 |
| Beta | 0.16 |
| 1 Month Change | 7.48% |
| 3 Month Change | -15.57% |
| 1 Year Change | -49.34% |
| 3 Year Change | 89.14% |
| 5 Year Change | 71.13% |
| Change since IPO | -30.72% |
Recent News & Updates
Shareholder Returns
| 6586 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -1.0% | -4.9% | -2.6% |
| 1Y | -49.3% | 1.7% | 25.9% |
Return vs Industry: 6586 underperformed the TW Pharmaceuticals industry which returned 1.7% over the past year.
Return vs Market: 6586 underperformed the TW Market which returned 25.9% over the past year.
Price Volatility
| 6586 volatility | |
|---|---|
| 6586 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.4% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6586 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6586's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Chung-Yi Wu | www.chopharma.com |
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan.
CHO Pharma, Inc. Fundamentals Summary
| 6586 fundamental statistics | |
|---|---|
| Market cap | NT$12.31b |
| Earnings (TTM) | -NT$306.09m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-40.2x
P/E RatioIs 6586 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6586 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$306.09m |
| Earnings | -NT$306.09m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.43 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did 6586 perform over the long term?
See historical performance and comparison